137 related articles for article (PubMed ID: 19789903)
1. Total synthesis and antileishmanial activity of the natural occurring acetylenic fatty acids 6-heptadecynoic acid and 6-icosynoic acid.
Carballeira NM; Cartagena MM; Prada CF; Rubio CF; Balaña-Fouce R
Lipids; 2009 Oct; 44(10):953-61. PubMed ID: 19789903
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of marine α-methoxylated fatty acid analogs that effectively inhibit the topoisomerase IB from Leishmania donovani with a mechanism different from that of camptothecin.
Carballeira NM; Montano N; Alvarez-Velilla R; Prada CF; Reguera RM; Balaña-Fouce R
Mar Drugs; 2013 Sep; 11(10):3661-75. PubMed ID: 24084785
[TBL] [Abstract][Full Text] [Related]
3. 2-Alkynoic fatty acids inhibit topoisomerase IB from Leishmania donovani.
Carballeira NM; Cartagena M; Sanabria D; Tasdemir D; Prada CF; Reguera RM; Balaña-Fouce R
Bioorg Med Chem Lett; 2012 Oct; 22(19):6185-9. PubMed ID: 22932312
[TBL] [Abstract][Full Text] [Related]
4. First total synthesis of the (±)-2-methoxy-6-heptadecynoic acid and related 2-methoxylated analogs as effective inhibitors of the leishmania topoisomerase IB enzyme.
Carballeira NM; Cartagena M; Li F; Chen Z; Prada CF; Calvo-Alvarez E; Reguera RM; Balaña-Fouce R
Pure Appl Chem; 2012; 84(9):1867-1875. PubMed ID: 23118491
[TBL] [Abstract][Full Text] [Related]
5. Recent developments in the antiprotozoal and anticancer activities of the 2-alkynoic fatty acids.
Carballeira NM
Chem Phys Lipids; 2013; 172-173():58-66. PubMed ID: 23727443
[TBL] [Abstract][Full Text] [Related]
6. First Total Synthesis of ω-Phenyl Δ6 Fatty Acids and their Leishmanicidal and Anticancer Properties.
Carballeira NM; Morales-Guzman C; Alvarez-Benedicto E; Torres-Martinez Z; Delgado Y; Griebenow KH; Tinoco AD; Reguera RM; Perez-Pertejo Y; Carbajo-Andres R; Balana-Fouce R
Curr Top Med Chem; 2018; 18(5):418-427. PubMed ID: 29766807
[TBL] [Abstract][Full Text] [Related]
7. First total synthesis and antileishmanial activity of (Z)-16-methyl-11-heptadecenoic acid, a new marine fatty acid from the sponge Dragmaxia undata.
Carballeira NM; Montano N; Cintrón GA; Márquez C; Rubio CF; Prada CF; Balaña-Fouce R
Chem Phys Lipids; 2011 Feb; 164(2):113-7. PubMed ID: 21129369
[TBL] [Abstract][Full Text] [Related]
8. First total synthesis and antiprotozoal activity of (Z)-17-methyl-13-octadecenoic acid, a new marine fatty acid from the sponge Polymastia penicillus.
Carballeira NM; Montano N; Balaña-Fouce R; Prada CF
Chem Phys Lipids; 2009 Sep; 161(1):38-43. PubMed ID: 19527698
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and antileishmanial activity of C7- and C12-functionalized dehydroabietylamine derivatives.
Dea-Ayuela MA; Bilbao-Ramos P; Bolás-Fernández F; González-Cardenete MA
Eur J Med Chem; 2016 Oct; 121():445-450. PubMed ID: 27318121
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and molecular docking studies of 1-phenyl-4-glycosyl-dihydropyridines as potent antileishmanial agents.
Pandey VP; Bisht SS; Mishra M; Kumar A; Siddiqi MI; Verma A; Mittal M; Sane SA; Gupta S; Tripathi RP
Eur J Med Chem; 2010 Jun; 45(6):2381-8. PubMed ID: 20199824
[TBL] [Abstract][Full Text] [Related]
11. Discovery of a new antileishmanial hit in 8-nitroquinoline series.
Paloque L; Verhaeghe P; Casanova M; Castera-Ducros C; Dumètre A; Mbatchi L; Hutter S; Kraiem-M'rabet M; Laget M; Remusat V; Rault S; Rathelot P; Azas N; Vanelle P
Eur J Med Chem; 2012 Aug; 54():75-86. PubMed ID: 22608675
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of chromenochalcones and evaluation of their in vitro antileishmanial activity.
Narender T; Khaliq T; Shweta ; Nishi ; Goyal N; Gupta S
Bioorg Med Chem; 2005 Dec; 13(23):6543-50. PubMed ID: 16185885
[TBL] [Abstract][Full Text] [Related]
13. Antileishmanial activity evaluation of bis-lawsone analogs and DNA topoisomerase-I inhibition studies.
Sharma G; Chowdhury S; Sinha S; Majumder HK; Kumar SV
J Enzyme Inhib Med Chem; 2014 Apr; 29(2):185-9. PubMed ID: 23534930
[TBL] [Abstract][Full Text] [Related]
14. Arylanthranilodinitriles: a new biaryl class of antileishmanial agents.
Singh FV; Vatsyayan R; Roy U; Goel A
Bioorg Med Chem Lett; 2006 May; 16(10):2734-7. PubMed ID: 16503140
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and biological evaluation of new [1,2,4]triazino[5,6-b]indol-3-ylthio-1,3,5-triazines and [1,2,4]triazino[5,6-b]indol-3-ylthio-pyrimidines against Leishmania donovani.
Gupta L; Sunduru N; Verma A; Srivastava S; Gupta S; Goyal N; Chauhan PM
Eur J Med Chem; 2010 Jun; 45(6):2359-65. PubMed ID: 20371140
[TBL] [Abstract][Full Text] [Related]
16. Effect of pyrazoloquinoline derivatives on the growth of Leishmania donovani promastigotes.
Al-Qahtani A; Siddiqui YM; Bekhit AA; El-Sayed OA; Aboul-Enein HY; Al-Ahdalb MN
Arch Pharm (Weinheim); 2005 Oct; 338(10):484-7. PubMed ID: 16211660
[TBL] [Abstract][Full Text] [Related]
17. A Novel Spirooxindole Derivative Inhibits the Growth of Leishmania donovani Parasites both In Vitro and In Vivo by Targeting Type IB Topoisomerase.
Saha S; Acharya C; Pal U; Chowdhury SR; Sarkar K; Maiti NC; Jaisankar P; Majumder HK
Antimicrob Agents Chemother; 2016 Oct; 60(10):6281-93. PubMed ID: 27503653
[TBL] [Abstract][Full Text] [Related]
18. Alteration of fatty acid and sterol metabolism in miltefosine-resistant Leishmania donovani promastigotes and consequences for drug-membrane interactions.
Rakotomanga M; Saint-Pierre-Chazalet M; Loiseau PM
Antimicrob Agents Chemother; 2005 Jul; 49(7):2677-86. PubMed ID: 15980336
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of 2-(pyrimidin-2-yl)-1-phenyl-2,3,4,9-tetrahydro-1H-beta-carbolines as antileishmanial agents.
Kumar R; Khan S; Verma A; Srivastava S; Viswakarma P; Gupta S; Meena S; Singh N; Sarkar J; Chauhan PM
Eur J Med Chem; 2010 Aug; 45(8):3274-80. PubMed ID: 20457476
[TBL] [Abstract][Full Text] [Related]
20. In vitro leishmanicidal activity of naturally occurring chalcones.
Kayser O; Kiderlen AF
Phytother Res; 2001 Mar; 15(2):148-52. PubMed ID: 11268116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]